CD1C and esophageal squamous cell carcinoma: The percentages of CD1c+ mDCs, CD16+ mDCs, CD141+ mDCs and CD123+ pDCs among PBMCs in healthy donors and ESCC patients were preoperatively (pre-OP) evaluated by fluorescence activated cell sorting (FACS) and depicted as the histogram (Figure 1a).